Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 8, 2002, Pages 702-709

  Perry, Arie ^a   Kunz, Sarah N ^a   Fuller, Christine E ^a   Banerjee, Ruma ^a   Marley, Edith F ^b   Liapis, Helen ^a   Watson, Mark A ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUNRISE HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Epidermal growth factor receptor (EGFR); Fluorescence in situ hybridization (FISH); Malignant peripheral nerve sheath tumor; NF1; NF2; p16; Sarcoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; NEUROFIBROMIN; PROTEIN P16;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CHROMOSOME 17Q; CHROMOSOME 7P; CHROMOSOME 9P; CHROMOSOME DELETION; CHROMOSOME LOSS; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FIBROSARCOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FREQUENCY; HEMANGIOPERICYTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE SHEATH TUMOR; NEURILEMOMA; NEUROFIBROMA; PRIORITY JOURNAL; SPINDLE CELL CARCINOMA; SYNOVIAL SARCOMA;

EID: 0036330022     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.8.702     Document Type: Article

References (44)

1. Primary malignant tumors of peripheral nerve
2. Malignant peripheral nerve sheath tumors in neurofibromatosis 1
3. Cytogenetic analysis of soft tissue sarcomas. Recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST)
4. Cytogenetic findings in malignant peripheral nerve sheath tumors
5. Cytogenetic and histologic correlation of peripheral nerve sheath tumors of soft tissue
6. Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: Sporadic vs. neurofibromatosis-type-1-associated malignant schwannomas
7. Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group
8. Cytogenetic characterization of peripheral nerve sheath tumours: A report of the CHAMP study group
9. Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17
10. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis
11. Genetic alterations in a malignant schwannoma from a patient with neurofibromatosis (NFI)
12. Molecular genetic analysis of the von Recklinghausen neurofibromatosis (NFI) gene using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) method
13. Alterations at chromosome 17 loci in peripheral nerve sheath tumors
14. Analysis of chromosomal imbalances in sporadic and NFI-associated peripheral nerve sheath tumors by comparative genomic hybridization
15. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1
16. Analysis of the NF1 gene by temperature gradient gel electrophoresis reveals a high incidence of mutations in exon 4b
17. NFI deletions in S-100 protein-positive and negative cells of sporadic and Neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors
18. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: Studies of CDKN2A and other genes of the pRB pathway
19. Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas
20. Malignant transformation of neurofibromas in Neurofibromatosis 1 is associated with CDKN2A/p16 inactivation
21. Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models
22. Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors
23. A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas
24. Chromosome 7 abnormalities in prostate cancer detected by dual-color fluorescence in situ hybridization
25. Neurofibromatosis conference statement. National Institutes of Health Consensus Development Conference
26. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas
27. Malignant peripheral nerve sheath tumors. A clinicopathological study of 120 cases
28. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis
29. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population
30. A prospective 10-year follow-up study of patients with neurofibromatosis type 1
31. Mutation and cancer: Statistical study of retinoblastoma
32. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas
33. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas
34. Upregulation of specific NF1 gene transcripts in sporadic pilocytic astrocytomas
35. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas
36. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis
37. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: A correlative immunohistochemistry study of 175 cases
38. Detection of p16 gene deletions in gliomas: Fluorescence in situ hybridization (FISH) versus quantitative PCR
39. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas. Relationship to amplification and mRNA levels of CDK4 and CDND1
40. Loss of heterozygosity on chromosome 9p21 (p16 gene) uncommon in soft-tissue sarcomas
41. Gene alterations at the CDKN2A (p16/MTS1) locus in soft tissue tumors
42. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: Effect on survival
43. Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology